Viewing Study NCT01164150


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-01-28 @ 4:03 PM
Study NCT ID: NCT01164150
Status: TERMINATED
Last Update Posted: 2023-04-06
First Post: 2010-07-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Sponsor: Cancer Trials Ireland
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: CTRIAL-IE (ICORG) 09-06
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators